UroGen’s $120 Million Ordinary Shares Private Placement

Latham & Watkins represented the placement agents in the offering.UroGen Pharma Ltd. (Nasdaq: URGN) announced that it has entered into a definitive securities purchase agreement in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now